ARDS Flashcards

1
Q

Respiratory failure & types

A

Failure of the respiratory system to do one or both of: oxygenation & CO2 elimination (hypoxemic or hypercapnic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hypoxemic/Type I respiratory failure

A

Most common, PaO2 < 60mmHg, associated with alveolar oedema & most acute resp diseases (pneumonia, COPD, pul oedema, pneumothorax, ARDS)
* Ventilation perfusion mismatch usually due to fluid or bronchospasms
* Shunt: persistance of hypoxemia despite 100% O2 due to deoxygenated blood bypassing alveoli & mixing with oxygenated blood, decreasing arterial O2 content

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hypercapnic/Type II respiratory failure

A

PaCO2 > 50mmHg (COPD, asthma, overdose, ARDS, muscle & neurological disorders)
* Ventilatory demands exceeds supply, which can be due to reduced respiratory drive, muscular/neurological/chest wall abnormalities, increased CO2 production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is ARDS

A
  • Acute respiratory distress syndrome
  • Progressive respiratory failure whereby the alveolar-capillary interface is damaged, causing alvolar oedema & poor oxygenation
  • PaO2/FiO2 (fraction of inspired air) ratio < 200
  • High mortality rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aetiology

A

Develops from direct or indirect lung injury
* Sepsis (highest mortality rate) & SIRS
* Trauma
* Pneumonia, respiratory infections (flu)
* Burns
* Aspiration & inhalation injury
* Blood transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology Phases

A

Phase 1: injury/exudative (1-7 days after injury)
Phase 2: repairative/proliferative (1-2 weeks after injury)
Phase 3: fibrotic/chronic (2-3 weeks after)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PP - Injury/exudative phase

A
  • Lung injury or insult causes release of inflammatory mediators (neutrophils, histamine, serotonin, bradykinin)
  • Adhere to vascular endothelium = damages & increases permeability
  • Fluid passes into interstitial space, enlarges and pressure causes flow into alveoli
  • Inflammatory mediators cause bronchospasms
  • Damage also injurs type II alveolar cells, reducing surfactant production & causing alveolar collapse
  • RESULT = impaired gas exchange, reduced lung compliance, pulmonary shunting (deoxygenated blood into L side of heart due to lack of oxygenation = hypoxaemia)
  • Hypoxemia causes increased RR & CO, decreases TV to compensate BUT this fails due to increases atelectasis, pul oedema & shunt –> hypoventilation, decreased CO & tissue perfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PP - repairative/proliferative phase

A
  • Increase in neutrophils, monocytes, lymphocyts and fibroblasts = dense & fibrous lung tissue
  • Thickened alveolar membranes impairs diffusion = reduced oxygenation, lung compliance & shunting
  • If treated = lesions resolve
  • If left = widespread fibrosis (stiff lung)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PP - fibrotic/chronic phase

A
  • Widespread remodelling with fibrous tissue = reduced compliance, gas exchange & pulmonary HTN
  • May require long-term mechanical ventilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Early manifestations

A

Initial presentation is often subtle and may not show for 1-2 days
* Dyspnoea, tachypnoea/hyperventilation, shallow breathing, coughing
* Inspiratory crackles
* Hypoxemia & respiratory alkalosis (due to hyperventilation causing reduced CO2)
* Minimal signs of oedema on CXR < 30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Late manifestations

A
  • Evident respiratory distress (tachypnoea, diaphoresis, tachycardia, cyanosis, pallor, altered LOC) = requires ETT if continued (NB: HTN, tachy will progress to HoTN & brady)
  • Diffuse crackles & rhonchi (low tone wheezes due to oedema)
  • Complete white lung on CXR from consolidation
  • Hypoxemia despite increased oxygenation by mask etc = hallmark
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnostic Criteria

A
  • Symptoms
  • Aetiology (direct or indirect)
  • CXR (infiltration)
  • Diminished compliance
  • Gas exchange (PaO2/FiO2 < 200)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Patient Assessment

A

History: lung diseases, tobacco/toxins, recent trauma, obesity, previous intubation, O2/inhalers/immunosuppressants
Symptoms: (as previously), weight loss, chest pain, sleep changes, dizziness, headache, accessory muscles, change in mental state, ascites
Tests: CXR, TV/FVC, blood gasses (pCO2, pO2, SaO2, pH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment Goals

A

Goal:
* Maintain PaO2 > 60mmHg
* Normal pH through adequate ventilation
* Patent airway
* Sats > 90%
* Clear auscultation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment

A
  • High flow O2 (lowest effective dose to achieve PaO2 > 60mmHg) - necessary to treat refractory hypoxemia
  • Intubation is often required to maintain these levels
  • Higher levels of PEEP required to open collapsed alveoli but used with caution as it can compress capillary bed and lead to reduced L side return and reduce CO & BP
  • If unresponsive to other therapies = place patient in prone position to reduce heart pressure on lungs and improve ventillation/perfusion ratio or use continuous lateral rotation therapy
  • AB therapy if septic
  • Fluid restriction in primary insult, fluid resuscitation in secondary (to treat circulatory shock from sepsis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Complications of treatment

A
  • Ventilator associated pneumonia (infection control, elevate HOB to prevent aspiration)
  • Rupture of distended alevoli, resulting in air in other places e.g. pneumothorax (ventilate with smaller TVs)
  • Volutrauma - alveolar fracture (use smaller TV & pressure control)
  • Stress ulcers (prophylaxis, early enteral nutrition)
  • renal failure (from decreased oxygenation & meds for infection)
17
Q

Medications

A

Crystalloids/colloids: to treat reduced CO from ventilation & fluid shifts
Inotropic drugs: dopamine, dobutamine
PRBC: increase Hb & O2 carrying capacity

18
Q

Monitor

A
  • Vitals: HR, BP, RR (+ full assessment), sats - CVC or arterial line monitoring
  • Breath sounds
  • Blood gasses
  • CXR
  • Fluid balance & daily weight
  • Peripheral oedema
  • Pulmonary artery pressure
19
Q

Corticosteroids

A

Examples: dexamethasone, methylprednisolone
Indication: respiratory distress, inflammation, asthma, RA, allergies
Route: PO, IV, IM, SC
Mechanism: anti-inflammatory –> mediate release of inflammatory mediators and reduce alveolar epithelial injury by acting on glucocorticoid receptors that upregulates anti-inflammatory genes
Effect: reduce vascular permeability, fluid accumulation in alevoli and improved lung compliance and oxygen exchange = increases mortality and reduces ventilation requirements